Caribou Biosciences, Inc. (CRBU)
NASDAQ: CRBU · Real-Time Price · USD
1.250
-0.020 (-1.57%)
At close: Sep 16, 2026, 4:00 PM EDT
1.290
+0.040 (3.20%)
After-hours: Sep 16, 2026, 7:51 PM EDT
Caribou Biosciences Market Cap
Caribou Biosciences has a market cap or net worth of $134.01 million as of September 16, 2026. Its market cap has decreased by -21.36% in one year.
Market Cap
134.01M
Enterprise Value
46.85M
1-Year Change
-21.36%
Ranking
Category
Stock Price
$1.25
ChartMarket Cap Chart
Since the IPO on July 23, 2021, Caribou Biosciences's market cap has decreased from $888.48M to $134.01M, a decrease of -84.92%. That is a compound annual growth rate of -30.72%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2026 | 134.01M | -9.83% |
| Dec 31, 2025 | 148.61M | 3.22% |
| Dec 31, 2024 | 143.98M | -71.59% |
| Dec 29, 2023 | 506.71M | 32.27% |
| Dec 30, 2022 | 383.09M | -57.82% |
| Dec 31, 2021 | 908.30M | 2.23% |
| Jul 23, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NRx Pharmaceuticals | 147.09M |
| Kazia Therapeutics | 141.97M |
| Immunic | 141.49M |
| Corbus Pharmaceuticals Holdings | 133.84M |
| LENZ Therapeutics | 132.91M |
| Unicycive Therapeutics | 131.20M |
| Milestone Pharmaceuticals | 130.72M |
| Biomea Fusion | 130.47M |